SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

April 23, 2012 08:35 ET

MMRGlobal Recalibrates Sales and Marketing Strategy

LOS ANGELES, CA--(Marketwire - Apr 23, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced a major change in the Company's sales and marketing strategy, supplementing its existing distribution channels to build a faster bridge to revenue, starting immediately. MMR is a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals. The programs are expected to increase consumer usage of the Company's health IT products and services, which MMR believes will translate into immediate and scalable sales. Some of the programs include the following:

  • A MyMedicalRecords Personal Health Record Enrollment Kit will be distributed to customers of a major independent pharmacy chain in Southern California that fills or re-fills thousands of prescriptions a month, starting the first week of May. The pharmacy will encourage customers to activate their account and is being provided collateral materials to reinforce sign-ups. The pharmacy will then place prescription information directly into the customer's account on an ongoing basis.

  • MMR will launch a recurring direct marketing program with Pets Best insurance, also beginning in May, offering Personal Health Records to more than 300,000 pet owners. The landing page for this program can be seen at

  • MMR will attend the Visiting Nurse Associations of America Annual Meeting in Phoenix starting on May 2, and plans on signing up nursing agencies to distribute MyMedicalRecords directly to as many as four million patients through 90,000 VNAA member clinicians.

  • The Company has initiated the launch of the VIDA Senior Resource program through the distribution of 10,000 prepaid PHR cards enabling caregivers to activate personal health records in the home when visiting patients.

  • The MyMedicalRecords Prepaid Personal Health Record cards will be offered to a test group of 160,000 users as a member benefit in a well-known national fitness chain starting this summer.

  • MMR will begin home sales of PHRs as part of a suite of digital home products offered through 5,000 door-to-door sales representatives of Elevate. MMR plans on offering services starting this summer.

"The biggest challenge we have faced in marketing MyMedicalRecords is the resistance of people to change and begin the inevitable process of managing their personal health records online. This is also true of healthcare professionals, who tend to be conservative," said MMRGlobal Chairman and CEO Bob Lorsch. "We have spent the past three months taking a hard look at our sales, marketing and distribution strategies and recalibrating our targets so we are now shifting our emphasis from just touching potential users through employee benefits and insurance programs to aggressively building a critical mass of active PHR users. So beyond the doctor's office, our consumer-controlled PHR is being deployed through interactive distribution channels that can directly place the product into users' hands, reinforce the need to have a PHR, and also assist users in adopting the PHR. It is our experience that once consumers start to use their accounts, they continue to use them and remain paid subscribers."

"We are investing the marketing dollars that will begin to launch these programs over the next two quarters, which is expected to give us a measurable uptick in Q3 and then beyond from PHR user subscriptions. For example, there are more than 20,000 independent pharmacies in the U.S. that fill approximately 1.5 billion prescriptions annually. Simply adding an individual's or family's prescriptions in a MyMedicalRecords PHR should generate significant usage of PHRs," Lorsch added.

MMRGlobal will continue selling MMRPro and MMRPatientView to physician practices, surgery centers, hospitals and other healthcare professionals as well as marketing its PHR to existing employee benefit and insurance programs and continuing with its MedicAlert® Gold program. The Company will also continue to monetize both its health IT and biotech intellectual property assets.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's products and services at

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual results and the timing of selected events may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Such statements are subject to various risks and uncertainties, including but not limited to those discussed or incorporated by reference herein. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; success of new distribution channels and personal health records adoption; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions including the prepaid Personal Health Record card; ability to establish and maintain strategic relationships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio both in the U.S. and internationally; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information